A: Ce doped (YGd) 3 (GaAl) 5 O 12 :Ce (YGAG) is a ceramic scintillator originally developed for X-ray computed tomography (CT). It has high light output and is also a promising candidate for high resolution event-by-event radiation imaging detectors. Thus we developed a radiation imaging detector using a YGAG plate combined with a position sensitive photomultiplier tube (PSPMT) and evaluated the performance. The spatial resolution for Am-241 alpha particles (5.5 MeV) was ∼ 0.4 mm FWHM and the energy resolution was 12 % FWHM. The spatial resolution for Sr-Y-90 beta particles, Am-241 gammas (60 keV) and Cs-137 X-ray (∼ 35 keV) was 0.8 mm FWHM, 1.6 mm FWHM and 2.0 mm FWHM, respectively. The decay time difference of YGAG between 5.5 MeV alpha particles and 662 keV Cs-137 gammas was 37 ns and the pulse shape spectra for 5.5 MeV alpha particles and 662 keV Cs-137 gammas were separated without overlap with the figure of merit (FOM) of 1.14. It was possible to separate the alpha particle and gamma photon images using pulse shape discrimination. Using pulse shape discrimination, it was also possible to separate the alpha particles and gamma photons in the electrostatically collected radon daughters on the imaging detector. We conclude that the developed YGAG imaging detector is useful for high resolution radiation detector with pulse shape discrimination capability to discriminate the different types of radiations.
K: Detector design and construction technologies and materials; Dosimetry concepts and apparatus; Scintillators and scintillating fibres and light guides; Scintillators, scintillation and light emission processes (solid, gas and liquid scintillators) 1Corresponding author.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.